US Business

The Japanese auto maker outsold GM for the first time last year as a global computer-chip shortage dealt an uneven blow to car businesses. Tesla and Hyundai gained U.S. market share.

Canada has until Feb. 3 to comply with the U.S.-Mexico-Canada Agreement or the U.S. could begin the process of initiating tariffs or other countermeasures.

Early results were so impressive the company raced toward regulatory approval. But its decision to stop trials produced a therapy without proven efficacy that many patients aren’t taking; “potentially the worst drug launch of all time.”

The CDC expanded its recommendation to get boosters to children 5 to 11 years with weakened immune systems. It also said people who got Pfizer’s vaccine should get a booster 5 months later, down from 6.

The embattled property developer released data showing its financial stress had largely halted sales of new homes and said it had been ordered to tear down dozens of buildings on an extravagant man-made island in southern China.

The verdict caps the downfall of the former Silicon Valley star who claimed to revolutionize blood testing.

The telecom companies said they agreed to delay their rollout of a new 5G service for two weeks, reversing course after previously declining a request by U.S. transportation officials.

The iPhone maker’s shares closed below the milestone after a 41% jump since the beginning of 2021.

U.S. health regulators cleared use of a Covid-19 booster from Pfizer and BioNTech in adolescents 12 to 15 years old, expanding access to an extra dose that could bolster the fight against the Omicron variant.

Brewers struggle to retain a dwindling edge, as spirits makers campaign to grab market share using canned cocktails to burnish their product’s reputation and lower taxes on it. “Alcohol is alcohol.”